# Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

> **NCT06445322** · — · RECRUITING · sponsor: **Ascidian Therapeutics, Inc** · enrollment: 50 (estimated)

## Conditions studied

- Stargardt Disease
- Stargardt Disease 1
- Cone Rod Dystrophy
- Juvenile Macular Degeneration

## Interventions

- **DIAGNOSTIC_TEST:** Prescreening Assessments

## Key facts

- **NCT ID:** NCT06445322
- **Lead sponsor:** Ascidian Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-20
- **Primary completion:** 2027-08-31
- **Final completion:** 2030-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06445322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06445322, "Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06445322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*